Genetic Technologies provides details of a series of recent transformative initiatives. On Australian free to air television, Channel 9 News recently featured geneType’s pioneering Precision & Preventive Medicine Clinic, marking a milestone in healthcare. Situated at Gold Coast Private Hospital, in Queensland, this clinic is the first of its kind in Australia, representing a fusion of cutting-edge technology and healthcare excellence. The clinic’s establishment marks a significant leap forward in the integration of precision medicine into everyday healthcare practices. To highlight the importance of early detection, and therefore saving lives, geneType’s world-first risk assessment test for Melanoma was recently featured on Channel 7’s The Morning Show geneType ambassador, Deborah Hutton. GTG’s commitment to innovation continues with a groundbreaking partnership with the University of Melbourne. Genetic Technologies Limited has been named commercial partner for a $2.4 million Medical Research Future Fund grant funded trial, named CASSOWARY.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GENE:
- Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
- Genetic Technologies announces 1-for-100 share consolidation
- Genetic Technologies provides update on activities for the quarter
- Genetic announces paper on geneType’s Pancreatic Cancer risk test
- GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment